Brian Schwab
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Brian Schwab
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
33
| Public Company | Chemicals: Specialty | 33 |
| Public Company | Pharmaceuticals: Major | 10 | |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA.
7
| Extinct | Pharmaceuticals: Major | 7 |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.
6
| Extinct | Pharmaceuticals: Major | 6 |
Cooley Godward LLP
 Cooley Godward LLP Miscellaneous Commercial ServicesCommercial Services Cooley Goodword LLP is the law firm specializes in providing services to both new and established information technology and life sciences companies. Cooley also provides counsel in areas of business law that include trade regulation, employment and labor, investment banking issues, securities litigation, IPOs, mergers and acquisitions, patent enforcement and venture capital funding. It is located in Palo Alto, CA.
4
| Extinct | Miscellaneous Commercial Services | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Brian Schwab via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CYTEC INDUSTRIES INC | Chemicals: Specialty | Director/Board Member Chairman | |
| VERNALIS | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| AXA | Multi-Line Insurance | Director/Board Member Director/Board Member | |
| AGEAS SA/NV | Multi-Line Insurance | President Director/Board Member | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ALSTOM | Trucks/Construction/Farm Machinery | Director/Board Member Director/Board Member | |
| UPM-KYMMENE OYJ | Pulp & Paper | Director/Board Member Director/Board Member | |
| SAINT-GOBAIN | Building Products | Director/Board Member Director/Board Member | |
Solvay France SA
 Solvay France SA Chemicals: Major DiversifiedProcess Industries Solvay France SA engages in the production of specialty chemicals. The company was founded in 1863 and is headquartered in Paris, France. | Chemicals: Major Diversified | Chairman Director/Board Member Chief Executive Officer General Counsel Director/Board Member Corporate Officer/Principal | |
Parion Sciences, Inc.
 Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
World Business Council for Sustainable Development
 World Business Council for Sustainable Development Miscellaneous Commercial ServicesCommercial Services The World Business Council for Sustainable Development operates as a business development association. The non-profit company is based in Geneva, Switzerland. The Swiss company was founded in 1990 by Bertrand P. Collomb. M. Peter Bakker has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
| AIRBUS SE | Aerospace & Defense | Director/Board Member Director/Board Member | |
| FORVIA (EX-FAURECIA) | Auto Parts: OEM | Director/Board Member Director/Board Member | |
Ventech SA
 Ventech SA Investment ManagersFinance Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US. | Investment Managers | Private Equity Investor | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | General Counsel Corporate Officer/Principal | |
| ELIOR GROUP | Restaurants | Investor Relations Contact Director/Board Member | |
| University of Michigan | College/University | Graduate Degree Graduate Degree | |
| Erasmus University Rotterdam | College/University | Graduate Degree Masters Business Admin | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member | |
| Sciences Po | College/University | Graduate Degree Undergraduate Degree | |
| École Centrale Paris | College/University | Undergraduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Rennes | College/University | Doctorate Degree Graduate Degree | |
| École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree Undergraduate Degree | |
| Medical College of Virginia | College/University | Doctorate Degree | |
| Ecole Nationale de la Statistique & de l'Administration | College/University | Undergraduate Degree Undergraduate Degree | |
| Ecole Nationale d'Administration | College/University | Undergraduate Degree Undergraduate Degree | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member | |
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member | |
| Western University of Health Sciences | College/University | Undergraduate Degree | |
| Université Catholique de Louvain | College/University | Jean Baptiste Henri van Zeebroeck | Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree |
Conseil Européen de l'industrie Chimique - European Chemical
 Conseil Européen de l'industrie Chimique - European Chemical Wholesale DistributorsDistribution Services Conseil Européen de l'industrie Chimique, also known as the European Chemical Industry Council (Cefic), is a non-profit organization that represents large, medium, and small chemical companies across Europe. The non-profit company was founded in 1972 and is based in Brussels, Belgium, with subsidiaries in Belgium. Cefic is committed to the UN sustainability agenda and has developed a unique roadmap, called the Transition Pathway, to guide the European chemicals industry through the massive transformation needed to meet the EU Green Deal goals. The Transition Pathway lays out more than 200 actions for the EU institutions, Member State governments, and industry to build the business case for investing in sustainability. Cefic provides clarity, predictability, and direction to guide the industry through the transition. | Wholesale Distributors | Director/Board Member President | |
Automobiles Citroën SA
 Automobiles Citroën SA Specialty StoresRetail Trade Automobiles Citroën SA engages in the manufactures and distribution of cars. It also sells second-hand vehicles. The firm also offers maintenance, repair, assistance, and financing services. The company was founded by André Citroën in 1919 and is headquartered in Paris, France. | Specialty Stores | Chairman Corporate Officer/Principal | |
Covagen AG
 Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member | |
Millendo Therapeutics SAS
 Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Medical Specialties | Director/Board Member | |
SolVin SA
 SolVin SA Chemicals: SpecialtyProcess Industries SolVin SA manufactures polyvinyl chloride resins. It serves automotive, building architecture, chemical industry, consumer goods, electrical equipment, human health, packaging, and water and the environment industries. The company was founded in 1999 and is based in Brussels, Belgium. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| MEDEF International | President Director/Board Member | ||
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
| École Nationale Supérieure de Chimie de Paris | College/University | Undergraduate Degree Undergraduate Degree | |
| Finbiomed SARL | Chief Executive Officer | ||
| SYENSQO SA/NV | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Chairman Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Frankrijk | 27 |
| Verenigde Staten | 11 |
| België | 7 |
| Verenigd Koninkrijk | 3 |
| Zwitserland | 3 |
Sectoraal
| Consumer Services | 17 |
| Health Technology | 13 |
| Process Industries | 6 |
| Commercial Services | 6 |
| Finance | 4 |
Operationeel
| Director/Board Member | 342 |
| Corporate Officer/Principal | 130 |
| Independent Dir/Board Member | 113 |
| Chairman | 89 |
| Chief Executive Officer | 52 |
Sterkste connecties
- Beurs
- Insiders
- Brian Schwab
- Bedrijfsconnecties
